Liontrust Investment Partners LLP Sells 17,798 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Liontrust Investment Partners LLP decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.2% in the first quarter, Holdings Channel reports. The firm owned 271,116 shares of the medical equipment provider’s stock after selling 17,798 shares during the quarter. Intuitive Surgical comprises about 2.1% of Liontrust Investment Partners LLP’s portfolio, making the stock its 11th biggest holding. Liontrust Investment Partners LLP’s holdings in Intuitive Surgical were worth $134,276,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG raised its stake in shares of Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock valued at $99,678,000 after acquiring an additional 883 shares during the last quarter. Evergreen Capital Management LLC raised its stake in shares of Intuitive Surgical by 2.7% in the fourth quarter. Evergreen Capital Management LLC now owns 4,268 shares of the medical equipment provider’s stock valued at $2,228,000 after acquiring an additional 112 shares during the last quarter. Main Street Financial Solutions LLC raised its stake in shares of Intuitive Surgical by 82.0% in the fourth quarter. Main Street Financial Solutions LLC now owns 2,808 shares of the medical equipment provider’s stock valued at $1,466,000 after acquiring an additional 1,265 shares during the last quarter. Finally, Farringdon Capital Ltd. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $395,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating and cut their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Royal Bank Of Canada raised their price target on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 23rd. Finally, UBS Group raised their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $595.95.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. The trade was a 13.13% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,839 shares of company stock valued at $7,896,972. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.1%

NASDAQ:ISRG opened at $477.08 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $171.02 billion, a P/E ratio of 66.54, a P/E/G ratio of 5.06 and a beta of 1.59. The stock’s fifty day simple moving average is $510.29 and its 200-day simple moving average is $526.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the company earned $1.78 EPS. The firm’s revenue was up 21.4% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.